At the moment, the data is still incomplete. The preliminary data I've already seen about the fourth dose seems to show a very moderate benefit in this context. I think you would have to have vaccines tailored to the emerging variants to have an effect on long COVID. I say that with considerable reservations, because we still need a lot of data.
On March 30th, 2022. See this statement in context.